COEP

$0.00

(

0.00%

) Quote details
Add to Watchlist Run Backtest
stock

Coeptis Therapeutics Inc

NASDAQ | COEP

15.53

USD

$0.00

(

0.00%

)

At Close (As of Oct 14, 2025)

$74.96M

Market Cap

-

P/E Ratio

-6.87

EPS

$19.19

52 Week High

$2.31

52 Week Low

HEALTHCARE

Sector

COEP Chart

Recent Chart
Price Action

COEP Technicals

Tags:

COEP Earnings

Yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit -$1M
Total Revenue $0
Cost Of Revenue $1M
Costof Goods And Services Sold $1M
Operating Income -$10M
Selling General And Administrative $946K
Research And Development $2.3M
Operating Expenses $10M
Investment Income Net -
Net Interest Income -$396K
Interest Income -
Interest Expense $396K
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $1M
Income Before Tax -$11M
Income Tax Expense -$1.1M
Interest And Debt Expense -
Net Income From Continuing Operations -$11M
Comprehensive Income Net Of Tax -
Ebit -$10M
Ebitda -$9.4M
Net Income -$9.8M

Revenue & Profitability

Earnings Performance

COEP Financials

yearly Balance Sheet (As of Dec 31, 2024)

Field Value (USD)
Total Assets $8.9M
Total Current Assets $1.1M
Cash And Cash Equivalents At Carrying Value $533K
Cash And Short Term Investments $533K
Inventory -
Current Net Receivables $39K
Total Non Current Assets $7.9M
Property Plant Equipment -
Accumulated Depreciation Amortization Ppe -
Intangible Assets $542K
Intangible Assets Excluding Goodwill $542K
Goodwill -
Investments -
Long Term Investments $5.7M
Short Term Investments -
Other Current Assets $518K
Other Non Current Assets -
Total Liabilities $5M
Total Current Liabilities $4.5M
Current Accounts Payable $1.3M
Deferred Revenue -
Current Debt -
Short Term Debt $1.2M
Total Non Current Liabilities $528K
Capital Lease Obligations $61K
Long Term Debt $150K
Current Long Term Debt $1.2M
Long Term Debt Noncurrent -
Short Long Term Debt Total $1.4M
Other Current Liabilities $2M
Other Non Current Liabilities -
Total Shareholder Equity $3.2M
Treasury Stock -
Retained Earnings -$98M
Common Stock $212
Common Stock Shares Outstanding $1.9M

yearly Cash Flow (As of Dec 31, 2024)

Field Value (USD)
Operating Cashflow -$6.6M
Payments For Operating Activities -
Proceeds From Operating Activities -
Change In Operating Liabilities -
Change In Operating Assets -
Depreciation Depletion And Amortization $1M
Capital Expenditures $4
Change In Receivables -
Change In Inventory -
Profit Loss -
Cashflow From Investment -
Cashflow From Financing $5.7M
Proceeds From Repayments Of Short Term Debt -
Payments For Repurchase Of Common Stock -
Payments For Repurchase Of Equity -
Payments For Repurchase Of Preferred Stock -
Dividend Payout -
Dividend Payout Common Stock -
Dividend Payout Preferred Stock -
Proceeds From Issuance Of Common Stock -
Proceeds From Issuance Of Long Term Debt And Capital Securities Net -
Proceeds From Issuance Of Preferred Stock -
Proceeds From Repurchase Of Equity -
Proceeds From Sale Of Treasury Stock -
Change In Cash And Cash Equivalents -
Change In Exchange Rate -
Net Income -$11M

yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit -$1M
Total Revenue $0
Cost Of Revenue $1M
Costof Goods And Services Sold $1M
Operating Income -$10M
Selling General And Administrative $946K
Research And Development $2.3M
Operating Expenses $10M
Investment Income Net -
Net Interest Income -$396K
Interest Income -
Interest Expense $396K
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $1M
Income Before Tax -$11M
Income Tax Expense -$1.1M
Interest And Debt Expense -
Net Income From Continuing Operations -$11M
Comprehensive Income Net Of Tax -
Ebit -$10M
Ebitda -$9.4M
Net Income -$9.8M

COEP News

COEP Profile

Coeptis Therapeutics Inc Profile

Sector: HEALTHCARE

Industry: BIOTECHNOLOGY

Coeptis Therapeutics Inc. is a biopharmaceutical company focused on the development and commercialization of innovative therapies for cancer patients, leveraging both brand-name and generic pharmaceuticals alongside advanced cell therapy platforms. Headquartered in Wexford, Pennsylvania, Coeptis is dedicated to addressing unmet medical needs within the oncology space, aiming to enhance treatment outcomes and improve quality of life for patients. With a strong emphasis on research and development, the company is poised to deliver breakthrough solutions in cancer therapeutics, positioning itself as a significant player in the biopharmaceutical landscape.

VHAI
+66.66%
$0.00
YYAI
-11.76%
$0.15
BURU
-20.39%
$0.40
UGRO
+54.52%
$0.57
NVDA
-4.40%
$180.03
CGBS
-39.47%
$0.03
PLUG
+6.26%
$4.14
BITF
+28.33%
$5.39
NVTS
+26.07%
$12.57
TMQ
+59.90%
$10.49
RGTI
+2.20%
$56.12
CAN
+18.42%
$1.80
DNN
+3.73%
$3.19
INTC
-4.27%
$35.63
LAES
+24.79%
$7.65
BYND
-23.22%
$0.79
JOBY
+8.05%
$18.12
RR
+4.34%
$6.73
RXRX
+6.50%
$5.89
SSKN
+41.55%
$2.18
ITP
+31.05%
$0.34
F
+1.08%
$11.66
EDHL
+114.42%
$1.07
CRML
+28.73%
$29.97
WULF
+10.42%
$15.46
ACHR
+1.91%
$13.01
BBD
+2.10%
$3.15
SOUN
+8.98%
$20.86
NAK
+4.13%
$2.76
SOFI
+2.68%
$27.87
TLRY
-5.32%
$1.60
QBTS
+5.93%
$43.03
DVLT
+24.76%
$2.12
IONZ
+11.73%
$2.57
BTBT
+3.25%
$4.13
GPUS
-6.93%
$0.40
MARA
+9.88%
$22.24
TSLA
-1.52%
$429.24
AMD
+0.77%
$218.09
AXDX
-61.36%
$0.03
CLF
+0.83%
$13.94
QS
+15.57%
$16.98
ERIC
+20.56%
$9.85
RIG
-2.65%
$3.11
ETHD
+6.45%
$3.54
CIFR
+2.70%
$20.89
NIO
-5.15%
$6.81
QUBT
+1.49%
$21.78
NUAI
+30.63%
$3.07
UAMY
+4.24%
$17.42
ASST
-7.69%
$0.99
NOK
+4.28%
$5.47
CLSK
+9.68%
$21.98
PLTR
+1.42%
$179.74
APLD
+2.33%
$35.04
IREN
+8.16%
$69.37
AREC
+36.74%
$6.81
ABAT
+36.59%
$9.22
RF
+2.40%
$25.15
BTG
+0.94%
$5.36
KDLY
-1.56%
$0.85
AAL
+1.90%
$11.74
USAR
-2.72%
$37.62
UUUU
+16.86%
$23.77
PFE
-0.82%
$24.52
BAC
+2.45%
$50.06
SNAP
-1.61%
$7.92
BMNR
-6.84%
$52.96
RMBL
+60.50%
$3.21
MP
+3.78%
$98.66
ADAP
-2.59%
$0.18
AMZN
-1.69%
$216.34
T
+2.11%
$26.13
ADD
-25.47%
$0.05
JBLU
+7.91%
$4.91
ONDS
-3.70%
$10.41
AAPL
+0.04%
$247.77
SRM
+53.27%
$10.30
AQMS
+198.89%
$29.62
HPE
+0.76%
$24.99
IONQ
-5.50%
$77.56
BCRX
-8.59%
$6.43
EOSE
-0.41%
$16.98
NAKA
-7.78%
$0.78
KDP
+2.32%
$26.42
GRAB
-0.33%
$5.91
RGTZ
-4.94%
$8.84
GWH
-15.91%
$7.61
BULL
-0.08%
$11.73
DFLI
-2.54%
$1.53
ABEV
+1.16%
$2.16
VALE
+2.41%
$11.01
CUTR
-10.19%
$0.09
PET
-59.91%
$0.04
NB
+3.09%
$11.67
WLGS
-5.57%
$0.04
GDXD
+3.16%
$0.75
FHN
+2.47%
$23.00
WWR
+29.29%
$2.56
ETWO
0.00%
$3.30
VHAI
+66.66%
$0.00
YYAI
-11.76%
$0.15
BURU
-20.39%
$0.40
UGRO
+54.52%
$0.57
NVDA
-4.40%
$180.03
CGBS
-39.47%
$0.03
PLUG
+6.26%
$4.14
BITF
+28.33%
$5.39
NVTS
+26.07%
$12.57
TMQ
+59.90%
$10.49
RGTI
+2.20%
$56.12
CAN
+18.42%
$1.80
DNN
+3.73%
$3.19
INTC
-4.27%
$35.63
LAES
+24.79%
$7.65
BYND
-23.22%
$0.79
JOBY
+8.05%
$18.12
RR
+4.34%
$6.73
RXRX
+6.50%
$5.89
SSKN
+41.55%
$2.18
ITP
+31.05%
$0.34
F
+1.08%
$11.66
EDHL
+114.42%
$1.07
CRML
+28.73%
$29.97
WULF
+10.42%
$15.46
ACHR
+1.91%
$13.01
BBD
+2.10%
$3.15
SOUN
+8.98%
$20.86
NAK
+4.13%
$2.76
SOFI
+2.68%
$27.87
TLRY
-5.32%
$1.60
QBTS
+5.93%
$43.03
DVLT
+24.76%
$2.12
IONZ
+11.73%
$2.57
BTBT
+3.25%
$4.13
GPUS
-6.93%
$0.40
MARA
+9.88%
$22.24
TSLA
-1.52%
$429.24
AMD
+0.77%
$218.09
AXDX
-61.36%
$0.03
CLF
+0.83%
$13.94
QS
+15.57%
$16.98
ERIC
+20.56%
$9.85
RIG
-2.65%
$3.11
ETHD
+6.45%
$3.54
CIFR
+2.70%
$20.89
NIO
-5.15%
$6.81
QUBT
+1.49%
$21.78
NUAI
+30.63%
$3.07
UAMY
+4.24%
$17.42
ASST
-7.69%
$0.99
NOK
+4.28%
$5.47
CLSK
+9.68%
$21.98
PLTR
+1.42%
$179.74
APLD
+2.33%
$35.04
IREN
+8.16%
$69.37
AREC
+36.74%
$6.81
ABAT
+36.59%
$9.22
RF
+2.40%
$25.15
BTG
+0.94%
$5.36
KDLY
-1.56%
$0.85
AAL
+1.90%
$11.74
USAR
-2.72%
$37.62
UUUU
+16.86%
$23.77
PFE
-0.82%
$24.52
BAC
+2.45%
$50.06
SNAP
-1.61%
$7.92
BMNR
-6.84%
$52.96
RMBL
+60.50%
$3.21
MP
+3.78%
$98.66
ADAP
-2.59%
$0.18
AMZN
-1.69%
$216.34
T
+2.11%
$26.13
ADD
-25.47%
$0.05
JBLU
+7.91%
$4.91
ONDS
-3.70%
$10.41
AAPL
+0.04%
$247.77
SRM
+53.27%
$10.30
AQMS
+198.89%
$29.62
HPE
+0.76%
$24.99
IONQ
-5.50%
$77.56
BCRX
-8.59%
$6.43
EOSE
-0.41%
$16.98
NAKA
-7.78%
$0.78
KDP
+2.32%
$26.42
GRAB
-0.33%
$5.91
RGTZ
-4.94%
$8.84
GWH
-15.91%
$7.61
BULL
-0.08%
$11.73
DFLI
-2.54%
$1.53
ABEV
+1.16%
$2.16
VALE
+2.41%
$11.01
CUTR
-10.19%
$0.09
PET
-59.91%
$0.04
NB
+3.09%
$11.67
WLGS
-5.57%
$0.04
GDXD
+3.16%
$0.75
FHN
+2.47%
$23.00
WWR
+29.29%
$2.56
ETWO
0.00%
$3.30
2025 © AfterPullback LTD

Charts powered by TradingView

Market data may be delayed by 15 minutes or more and is provided by financial exchanges or third-party providers. AfterPullback does not verify or guarantee its accuracy and assumes no responsibility to do so. This website is not operated by a licensed attorney, accountant, or financial advisor. Nothing on this site constitutes financial advice or replaces consultation with a qualified professional who understands your specific circumstances. Always consult a licensed financial advisor before making investment decisions.